{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:44:19Z","timestamp":1769730259551,"version":"3.49.0"},"reference-count":47,"publisher":"IMR Press","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Changzhou Municipal Health Commission Science and Technology Project","award":["QY202401"],"award-info":[{"award-number":["QY202401"]}]},{"name":"Changzhou Science and Technology Plan Project","award":["CE20235060"],"award-info":[{"award-number":["CE20235060"]}]},{"name":"Changzhou Science and Technology Project","award":["CJ20243014"],"award-info":[{"award-number":["CJ20243014"]}]},{"name":"Changzhou Science and Technology Project","award":["CJ20243015"],"award-info":[{"award-number":["CJ20243015"]}]},{"name":"Changzhou Science and Technology Project","award":["CJ20230047"],"award-info":[{"award-number":["CJ20230047"]}]},{"name":"Changzhou Clinical Medical Center and the Outstanding Talent of Changzhou \u201cThe 14th Five-Year Plan\u201d High-Level Health Talents Training Project"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Monoclonal gammopathy of undetermined significance (MGUS) is a precursor to multiple myeloma (MM), but the mechanisms of progression remain unclear. Methods and Objectives: Transcriptomic datasets procured from the Gene Expression Omnibus (GEO) underwent thorough analysis to ascertain disease-related modules using weighted gene co-expression network analysis. A prognostic model (MGUSscore) was constructed via least absolute shrinkage and selection operator (LASSO) regression within the GSE136337 cohort and validated across independent datasets (The Cancer Genome Atlas - multiple myeloma [TCGA-MM], GSE4581, GSE57317). Crucially, the investigation integrated original single-cell ATAC-seq profiling, immune landscape characterization, and pharmacogenomic sensitivity prediction. Protein-level disparities were validated in clinical specimens using immunohistochemistry and multiplex immunofluorescence. Results: DAP3 and UBE2S were identified as central drivers of progression. The MGUSscore effectively stratified patients into risk categories, with high-risk individuals exhibiting significantly inferior survival outcomes (p &lt; 0.001). Notably, the high-risk group was characterized by distinct immune infiltration patterns and predicted responsiveness to specific chemotherapies. Experimental validation confirmed markedly elevated DAP3 and UBE2S protein expression in MM compared to MGUS tissues. Conclusion: Collectively, DAP3 and UBE2S may constitute promising therapeutic targets for MM intervention, meriting additional investigative efforts.<\/jats:p>","DOI":"10.31083\/fbl46992","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:05:26Z","timestamp":1769688326000},"source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Molecular Mechanisms and Shared Genetic Characteristics of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0376-4215","authenticated-orcid":true,"given":"Yuanjing","family":"Fu","sequence":"first","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital of Soochow University, 213003 Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4913-1610","authenticated-orcid":true,"given":"Weiying","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital of Soochow University, 213003 Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6071-5492","authenticated-orcid":true,"given":"Yan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital of Soochow University, 213003 Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital of Soochow University, 213003 Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2630-5454","authenticated-orcid":true,"given":"Jiaru","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital of Soochow University, 213003 Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4776-1896","authenticated-orcid":true,"given":"He","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital of Soochow University, 213003 Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, 213003 Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3277-9998","authenticated-orcid":true,"given":"Zhuojun","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital of Soochow University, 213003 Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8683-8573","authenticated-orcid":true,"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Third Affiliated Hospital of Soochow University, 213003 Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Mikulasova A, Smetana J, Wayhelova M, Janyskova H, Sandecka V, Kufova Z, et al. Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance. European Journal of Haematology. 2016; 97: 568\u2013575.","DOI":"10.1111\/ejh.12774"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Steiner N, G\u00f6bel G, Suchecki P, Prokop W, Neuwirt H, Gunsilius E. Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients. Oncotarget. 2018; 9: 2344\u20132356.","DOI":"10.18632\/oncotarget.23412"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Kyle RA, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Cerhan JR, et al. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance. The New England Journal of Medicine. 2018; 378: 241\u2013249.","DOI":"10.1056\/NEJMoa1709974"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Korde N, Kristinsson SY, Landgren O. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies. Blood. 2011; 117: 5573\u20135581.","DOI":"10.1182\/blood-2011-01-270140"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Pang L, Rajkumar SV, Kapoor P, Buadi F, Dispenzieri A, Gertz M, et al. Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS). Blood Cancer Journal. 2021; 11: 26.","DOI":"10.1038\/s41408-021-00406-6"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and Management of Multiple Myeloma: A Review. JAMA. 2022; 327: 464\u2013477.","DOI":"10.1001\/jama.2022.0003"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"van Nieuwenhuijzen N, Spaan I, Raymakers R, Peperzak V. From MGUS to Multiple Myeloma, a Paradigm for Clonal Evolution of Premalignant Cells. Cancer Research. 2018; 78: 2449\u20132456.","DOI":"10.1158\/0008-5472.CAN-17-3115"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Zhang Y, Yu J, Xie X, Jiang F, Wu C. Application of Genomic Data in Translational Medicine During the Big Data Era. Frontiers in Bioscience (Landmark edition). 2024; 29, 7.","DOI":"10.31083\/j.fbl2901007"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Research. 2002; 30: 207\u2013210.","DOI":"10.1093\/nar\/30.1.207"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Chng WJ, Kumar S, Vanwier S, Ahmann G, Price-Troska T, Henderson K, et al. Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling. Cancer Research. 2007; 67: 2982\u20132989.","DOI":"10.1158\/0008-5472.CAN-06-4046"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Zhan F, Barlogie B, Arzoumanian V, Huang Y, Williams DR, Hollmig K, et al. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood. 2007; 109: 1692\u20131700.","DOI":"10.1182\/blood-2006-07-037077"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Danziger SA, McConnell M, Gockley J, Young MH, Rosenthal A, Schmitz F, et al. Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials. PLoS Medicine. 2020; 17: e1003323.","DOI":"10.1371\/journal.pmed.1003323"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Heuck CJ, Qu P, van Rhee F, Waheed S, Usmani SZ, Epstein J, et al. Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma. Leukemia. 2014; 28: 2410\u20132413.","DOI":"10.1038\/leu.2014.232"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research. 2015; 43: e47.","DOI":"10.1093\/nar\/gkv007"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9: 559.","DOI":"10.1186\/1471-2105-9-559"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics: a Journal of Integrative Biology. 2012; 16: 284\u2013287.","DOI":"10.1089\/omi.2011.0118"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nature Methods. 2015; 12: 453\u2013457.","DOI":"10.1038\/nmeth.3337"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Briefings in Bioinformatics. 2021; 22: bbab260.","DOI":"10.1093\/bib\/bbab260"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Zhong L, Hao P, Zhang Q, Jiang T, Li H, Xiao J, et al. Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma (MM). eLife. 2022; 11: e75340.","DOI":"10.7554\/eLife.75340"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021; 184: 3573\u20133587.e29.","DOI":"10.1016\/j.cell.2021.04.048"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nature Biotechnology. 2014; 32: 381\u2013386.","DOI":"10.1038\/nbt.2859"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Cao J, Spielmann M, Qiu X, Huang X, Ibrahim DM, Hill AJ, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature. 2019; 566: 496\u2013502.","DOI":"10.1038\/s41586-019-0969-x"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, et al. Reversed graph embedding resolves complex single-cell trajectories. Nature Methods. 2017; 14: 979\u2013982.","DOI":"10.1038\/nmeth.4402"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Uhlen M, Zhang C, Lee S, Sj\u00f6stedt E, Fagerberg L, Bidkhori G, et al. A pathology atlas of the human cancer transcriptome. Science (New York, N.Y.). 2017; 357: eaan2507.","DOI":"10.1126\/science.aan2507"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Dhodapkar MV. MGUS to myeloma: a mysterious gammopathy of underexplored significance. Blood. 2016; 128: 2599\u20132606.","DOI":"10.1182\/blood-2016-09-692954"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. American Journal of Hematology. 2020; 95: 548\u2013567.","DOI":"10.1002\/ajh.25791"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009; 113: 5412\u20135417.","DOI":"10.1182\/blood-2008-12-194241"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Khalili P, Maddah R, Maleknia M, Shateri Amiri B, Forouzani F, Hasanvand A, et al. Evaluation of Genes and Molecular Pathways Involved in the Progression of Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma: A Systems Biology Approach. Molecular Biotechnology. 2023; 65: 1275\u20131286.","DOI":"10.1007\/s12033-022-00634-6"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Rajan AM, Rajkumar SV. Interpretation of cytogenetic results in multiple myeloma for clinical practice. Blood Cancer Journal. 2015; 5: e365.","DOI":"10.1038\/bcj.2015.92"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Chiecchio L, Dagrada GP, Ibrahim AH, Dachs Cabanas E, Protheroe RKM, Stockley DM, et al. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context. Haematologica. 2009; 94: 1708\u20131713.","DOI":"10.3324\/haematol.2009.011064"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Kissil JL, Deiss LP, Bayewitch M, Raveh T, Khaspekov G, Kimchi A. Isolation of DAP3, a novel mediator of interferon-gamma-induced cell death. The Journal of Biological Chemistry. 1995; 270: 27932\u201327936.","DOI":"10.1074\/jbc.270.46.27932"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Sasaki H, Ide N, Yukiue H, Kobayashi Y, Fukai I, Yamakawa Y, et al. Arg and DAP3 expression was correlated with human thymoma stage. Clinical & Experimental Metastasis. 2004; 21: 507\u2013513.","DOI":"10.1007\/s10585-004-2153-3"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Jia Y, Li Z, Cheng X, Wu X, Pang F, Shi J, et al. Depletion of death-associated protein-3 induces chemoresistance in gastric cancer cells through the \u03b2-catenin\/LGR5\/Bcl-2 axis. Journal of Investigative Medicine. 2019; 67: 856\u2013861.","DOI":"10.1136\/jim-2018-000934"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Song H, Liu H, Wang X, Yang Y, Zhao X, Jiang WG, et al. Death-associated protein 3 in cancer-discrepant roles of DAP3 in tumours and molecular mechanisms. Frontiers in Oncology. 2024; 13: 1323751.","DOI":"10.3389\/fonc.2023.1323751"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Han J, An O, Ren X, Song Y, Tang SJ, Shen H, et al. Multilayered control of splicing regulatory networks by DAP3 leads to widespread alternative splicing changes in cancer. Nature Communications. 2022; 13: 1793.","DOI":"10.1038\/s41467-022-29400-7"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Zhang M, Wang J, Zhang Z, Guo Y, Lou X, Zhang L. Diverse roles of UBE2S in cancer and therapy resistance: Biological functions and mechanisms. Heliyon. 2024; 10: e24465.","DOI":"10.1016\/j.heliyon.2024.e24465"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Peng S, Chen X, Huang C, Yang C, Situ M, Zhou Q, et al. UBE2S as a novel ubiquitinated regulator of p16 and \u03b2-catenin to promote bone metastasis of prostate cancer. International Journal of Biological Sciences. 2022; 18: 3528\u20133543.","DOI":"10.7150\/ijbs.72629"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Lin M, Lei T, Zheng J, Chen S, Du L, Xie H. UBE2S mediates tumor progression via SOX6\/\u03b2-Catenin signaling in endometrial cancer. The International Journal of Biochemistry & Cell Biology. 2019; 109: 17\u201322.","DOI":"10.1016\/j.biocel.2019.01.014"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Jones JR, Weinhold N, Ashby C, Walker BA, Wardell C, Pawlyn C, et al. Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients. Haematologica. 2019; 104: 1440\u20131450.","DOI":"10.3324\/haematol.2018.202200"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Solimando AG, Malerba E, Leone P, Prete M, Terragna C, Cavo M, et al. Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche. Frontiers in Oncology. 2022; 12: 973836.","DOI":"10.3389\/fonc.2022.973836"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Arefi Sigaroudi N, Vakili Sadeghi M, Ghorbani H, Jahansouz D, Shirafkan H, Ranaee M. Prognosis of multiple myeloma patients based on histopathological evaluation of bone marrow. Caspian Journal of Internal Medicine. 2025; 16: 562\u2013569.","DOI":"10.22088\/cjim.16.3.562"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Zhang L, Zhong H, Fan J, Mao J, Li Y. Clinical significance of T helper cell subsets in the peripheral blood and bone marrow of patients with multiple myeloma. Frontiers in Immunology. 2024; 15: 1445530.","DOI":"10.3389\/fimmu.2024.1445530"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Ortiz A, Rodr\u00edguez-Garc\u00eda Y, Encinas J, Maroto-Mart\u00edn E, Castellano E, Teixid\u00f3 J, et al. The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression. Cancers. 2021; 13: 217.","DOI":"10.3390\/cancers13020217"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Ghaffari S, Rezaei N. Eosinophils in the tumor microenvironment: implications for cancer immunotherapy. Journal of Translational Medicine. 2023; 21: 551.","DOI":"10.1186\/s12967-023-04418-7"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Yasumura K, Sugimura I, Igarashi K, Kakinuma S, Nishimura M, Doi M, et al. Altered expression of Tfg and Dap3 in Ikaros-defective T-cell lymphomas induced by X-irradiation in B6C3F1 mice. British Journal of Haematology. 2004; 124: 179\u2013185.","DOI":"10.1046\/j.1365-2141.2003.04768.x"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Bao H, Luo Y, Ding G, Fu Z. A Pan-Cancer Analysis of UBE2S in Tumorigenesis, Prognosis, Pathway, Immune Infiltration and Evasion, and Therapy Response from an Immune-Oncology Perspective. Journal of Oncology. 2022; 2022: 3982539.","DOI":"10.1155\/2022\/3982539"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Desantis V, Savino FD, Scaringella A, Potenza MA, Nacci C, Frassanito MA, et al. The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value. Journal of Clinical Medicine. 2022; 11: 2513.","DOI":"10.3390\/jcm11092513"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/1\/10.31083\/FBL46992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:06:00Z","timestamp":1769688360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/1\/10.31083\/FBL46992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)00070-0"],"URL":"https:\/\/doi.org\/10.31083\/fbl46992","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"46992"}}